Jianxiang Liu
Shenyang Pharmaceutical University(CN)Qilu University of Technology(CN)Liaoning Technical University(CN)Shanghai University of Finance and Economics(CN)Beijing Academy of Artificial Intelligence(CN)Institute of Automation(CN)Shandong Academy of Sciences(CN)National Institute for Radiological Protection(CN)Guilin University of Electronic Technology(CN)Jiangxi Normal University(CN)Xiamen University of Technology(CN)Beihang University(CN)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, MicroRNA in disease regulation, Effects of Radiation Exposure, Cancer-related molecular mechanisms research, Gastroesophageal reflux and treatments
Most-Cited Works
- → Studies on Treatment of Acute Promyelocytic Leukemia With Arsenic Trioxide: Remission Induction, Follow-Up, and Molecular Monitoring in 11 Newly Diagnosed and 47 Relapsed Acute Promyelocytic Leukemia Patients(1999)626 cited
- → Role for CD47-SIRPα signaling in xenograft rejection by macrophages(2007)299 cited
- → Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance(2016)260 cited
- → Resveratrol Inhibits Ionising Irradiation-Induced Inflammation in MSCs by Activating SIRT1 and Limiting NLRP-3 Inflammasome Activation(2013)132 cited
- → LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway(2019)97 cited
- → Targeting of AML1-ETO in t(8;21) Leukemia by Oridonin Generates a Tumor Suppressor–Like Protein